DxMA 2017 Webcast #1
"Critical Issues for Your Molecular Laboratory Customers - How PAMA will Impact the Laboratory and Legal Considerations in Direct to Consumer Testing"
With pending reimbursement cuts from implementation of the Protecting Access to Medicare Act (PAMA), some molecular labs, including 23andMe, Color Genomics, Counsyl, Veritas Genetics and others, are forging a new business model that markets low-cost molecular tests directly to the consumers.
With pending reimbursement cuts from implementation of the Protecting Access to Medicare Act (PAMA), some molecular labs, including 23andMe, Color Genomics, Counsyl, Veritas Genetics and others, are forging a new business model that markets low-cost molecular tests directly to the consumers. This presentation from one of the largest legal practices in the country focused on clinical laboratories, will provide an overview of PAMA including the new method for calculating Medicare rates (including special rules applicable to certain LDTs), which labs must report, the data collection and reporting obligations of labs, the financial implications and threats posed by PAMA, and " flaws" in the PAMA methodology. The DTC portion will address FDA regulation and state law implications for DTC and legal do's and don'ts that laboratories face when launching a DTC program.
Rick is the manager of the firm’s National Healthcare Practice Group and is co-chair of its Healthcare Restructuring Practice Group. Rick served on the firm's Board of Directors from 1992-2012. He focuses his national practice in healthcare law, representing clients in transactional, restructuring, corporate, compliance, regulatory, licensure, reimbursement, contractual, strategic planning, and venture matters. Practice group clients include private practice and academic physician groups, hospitals and health systems (including tax-exempt, physician and investor owned hospitals, critical access to large systems and academic medical centers), physician networks, laboratories (anatomic, clinical, molecular, toxicology, and specialty), healthcare associations and societies, hospitalists and hospitalist
companies, multi-specialty clinics, medical staffs, imaging centers, surgery centers, outpatient medical facilities, home health providers, drug and alcohol treatment facilities, occupational medicine companies, healthcare technology companies, and healthcare billing and management companies.
Rick earned a J.D., cum laude, from Georgetown University Law Center in 1981. He received a B.A., cum laude, from Syracuse University in 1978.
Wednesday, March 15, 2017